Lv03
0 积分 2025-06-23 加入
Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast Cancer
4小时前
已完结
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
4小时前
已完结
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?
5小时前
已完结
乳腺癌治疗中的CDK4/6 抑制剂： 耐药机制和治疗策略
6小时前
已完结
对到 CDK4/6 抑制：克服激素受体阳性转移性乳腺癌治疗问题的机制和策略
1天前
已完结
对细胞周期蛋白依赖性激酶4/6抑制剂的耐药机制
1天前
已完结
皖公网安备34019202002308
